Genome-wide association studies burst onto the scene in the mid-2000s, and they are showing their worth for predicting disease risk, classifying disease, and examining gene-drug interactions, writes Muin Khoury, the director of the public health genomics office at the US Centers for Disease Control and Prevention, at the Genomics and Health Impact Blog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Gauge of Risk

No Average People

This Week in PLOS

Peace of Mind

In This Case…

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.